Bon Natural Life Business Summary

Bon Natural Life Ltd (BON) operates as a vertically integrated provider of natural health products, generating revenue through the research, development, and commercialization of functional active ingredients extracted from herb plants. The company’s business is divided into three primary segments: Fragrance Compounds, which supplies plant-extracted scents to the perfume and cosmetic industries; Health Supplements, focused on functional active ingredients for powdered nutritional drinks; and Bioactive Food Ingredients, which produces additives like stachyose and milk thistle extracts for the functional food and pharmaceutical sectors. BON primarily serves manufacturer-level customers across China, Europe, and North America, positioning itself as a high-tech extraction specialist. In the competitive landscape, BON contends with small-cap biotechnology and ingredient firms such as Acrivon Therapeutics, Instil Bio, and Aadi Bioscience, distinguishing itself through its proprietary extraction technologies and a dominant market presence in the Chinese natural ingredients sector. Founded in 2006 by Yongwei Hu, the company is led by a management team with deep technical and financial expertise. Yongwei Hu serves as the Chairman and Chief Executive Officer, maintaining significant voting control over the enterprise. The executive suite was recently strengthened by the appointment of Ma Xin as Chief Financial Officer in November 2025; Ma is a CFA charterholder and Washington State CPA with extensive experience in senior finance roles at several Nasdaq-listed entities. Other key leaders include Yingchun Xue (Chief Operating Officer), Wenjuan Chen (Chief Marketing Officer), and Jianli Liu, who serves as the Chief Technology Officer and Chief Scientist. The board of directors includes independent members such as Dr. Jianjun Gao and Jing Chen, providing oversight as the company executes its strategic expansion into the North American functional ingredient market.